Source: Annual Congress 2001 - Management of LRTI: clinical and outcomes assessment
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Biagini, M. Rossi (Arezzo, Italy). May the value of FEV1 be helpful in the choice of the antibiotic therapy in acute exacerbation of COPD?. Eur Respir J 2001; 16: Suppl. 31, 1352

Member's Comments

No comment yet.

Related content which might interest you: Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019 Year: 2019 FEV1 is a sensible marker of healing after antibiotic treatment in severe COPD outpatients affected with AECB Source: Eur Respir J 2001; 18: Suppl. 33, 190s Year: 2001 Is antibiotic treatment during asthma exacerbation necessary ? Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001 Clinically important deteriorations in COPD as a measure of response to dual and mono bronchodilator therapy with and without inhaled corticosteroids Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019 Year: 2019 Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019 Year: 2019 The rationality of the use of NIV in elderly patients with acute COPD exacerbation Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure Year: 2018 FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline? Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?” Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Should the number of acute exacerbations in the previous year be used to guide treatments in COPD? Source: Eur Respir J, 57 (2) 2002122; 10.1183/13993003.02122-2020 Year: 2021 The clinical utility of forced oscillation technique during hospitalisation in patients with exacerbation of COPD Source: ERJ Open Res, 7 (4) 00448-2021; 10.1183/23120541.00448-2021 Year: 2021 Predictors of poor outcome in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) receiving noninvasive positive pressure ventilation (NPPV Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure Year: 2015 What is the role of prophylactic antibiotic therapy in chronic bronchitis or COPD? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Should we change our antibiotic strategy in AECOPD or CAP+COPD patients? Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients Year: 2015 Utility of non-invasive ventilation as first-line intervention in respiratory failure due to acute exacerbation of asthma Source: Annual Congress 2010 - Noninvasive ventilation in the acute patient: outcome and pathophysiology Year: 2010 Acute exacerbation of bronchiectasis and the impact on the duration of antibiotic therapy Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019